Trial · NCT00910689
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Month 1: Optimal Acute Therapy Run in | STARTED | OAT + Placebo (PL) | 55 | |
| Month 1: Optimal Acute Therapy Run in | STARTED | OAT + Beta Blocker (Beta-B) | 53 | |
| Month 1: Optimal Acute Therapy Run in | STARTED | OAT + BMM + PL | 55 | |
| Month 1: Optimal Acute Therapy Run in | STARTED | OAT + BMM + Beta-B | 69 | |
| Month 1: Optimal Acute Therapy Run in | COMPLETED | OAT + Placebo (PL) | 53 | |
| Month 1: Optimal Acute Therapy Run in | COMPLETED | OAT + Beta Blocker (Beta-B) | 52 | |
| Month 1: Optimal Acute Therapy Run in | COMPLETED | OAT + BMM + PL | 50 | |
| Month 1: Optimal Acute Therapy Run in | COMPLETED | OAT + BMM + Beta-B | 59 | |
| Month 1: Optimal Acute Therapy Run in | NOT COMPLETED | OAT + Placebo (PL) | 2 | |
| Month 1: Optimal Acute Therapy Run in | NOT COMPLETED | OAT + Beta Blocker (Beta-B) | 1 | |
| Month 1: Optimal Acute Therapy Run in | NOT COMPLETED | OAT + BMM + PL | 5 | |
| Month 1: Optimal Acute Therapy Run in | NOT COMPLETED | OAT + BMM + Beta-B | 10 | |
| Month 2- 4: Treatment Period | STARTED | OAT + Placebo (PL) | 53 | |
| Month 2- 4: Treatment Period | STARTED | OAT + Beta Blocker (Beta-B) | 52 | |
| Month 2- 4: Treatment Period | STARTED | OAT + BMM + PL | 50 | |
| Month 2- 4: Treatment Period | STARTED | OAT + BMM + Beta-B | 59 | |
| Month 2- 4: Treatment Period | COMPLETED | OAT + Placebo (PL) | 44 | |
| Month 2- 4: Treatment Period | COMPLETED | OAT + Beta Blocker (Beta-B) | 42 | |
| Month 2- 4: Treatment Period | COMPLETED | OAT + BMM + PL | 42 | |
| Month 2- 4: Treatment Period | COMPLETED | OAT + BMM + Beta-B | 48 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00910689/flow